Page 151 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 151

C  H   A   P  T  E   R




                    Adrenoceptor Agonists &                                                       9


                    Sympathomimetic Drugs




                                                                            *
                    Italo Biaggioni, MD, & David Robertson, MD










                       C ASE  STUD Y

                       A 68-year-old man presents with a complaint of light-  There was an  inadequate compensatory increase in heart
                       headedness on standing that is worse after meals and in   rate (from 84 to 88 bpm), considering the degree of ortho-
                       hot environments. Symptoms started about 4 years ago and   static hypotension. Physical examination is otherwise unre-
                       have slowly progressed to the point that he is disabled. He   markable  with no  evidence  of peripheral  neuropathy or
                       has fainted several times but always recovers conscious-  parkinsonian features. Laboratory examinations are negative
                       ness almost as soon as he falls. Review of symptoms reveals   except for plasma norepinephrine, which is low at 98 pg/mL
                       slight worsening of constipation, urinary retention out of   (normal for his age 250–400 pg/mL). A diagnosis of pure
                       proportion to prostate size, and decreased sweating. He is   autonomic failure is made, based on the clinical picture and
                       otherwise healthy with no history of hypertension, diabetes,   the absence of drugs that could induce orthostatic hypoten-
                       or Parkinson’s disease. Because of urinary retention, he was   sion and diseases commonly associated with autonomic
                       placed  on  the  α   antagonist  tamsulosin,  but  the  fainting   neuropathy (eg, diabetes, Parkinson’s disease). What precau-
                                    1
                       spells got worse. Physical examination revealed a blood pres-  tions should this patient observe in using sympathomimetic
                       sure of 167/84 mm Hg supine and 106/55 mm Hg standing.    drugs? Can such drugs be used in his treatment?




                    The  sympathetic  nervous  system  is  an  important  regulator of   Drugs that mimic the actions of epinephrine or norepineph-
                    virtually  all  organ  systems.  This  is  particularly  evident  in  the   rine have traditionally been termed  sympathomimetic drugs.
                    regulation of blood pressure. As illustrated in the case study, the   The sympathomimetics can be grouped by mode of action and
                    autonomic nervous system is crucial for the maintenance of blood   by  the  spectrum of receptors  that  they  activate.  Some  of  these
                    pressure even under relatively minor situations of stress (eg, the   drugs (eg, norepinephrine and epinephrine) are  direct agonists;
                    gravitational stress of standing).                   they directly interact with and activate adrenoceptors. Others
                       The ultimate effects of sympathetic stimulation are mediated   are indirect agonists because their actions are dependent on their
                    by release of norepinephrine from nerve terminals, which then   ability to enhance the actions of endogenous catecholamines by
                    activates adrenoceptors on postsynaptic sites (see Chapter 6).   (1) inducing the release of catecholamines by displacing them
                    Also, in response to a variety of stimuli such as stress, the adrenal   from adrenergic nerve endings (eg, the mechanism of action of
                    medulla releases epinephrine, which is transported in the blood   tyramine), (2) decreasing the clearance of catecholamines by
                    to target tissues. In other words, epinephrine acts as a hormone,   inhibiting their neuronal reuptake (eg, the mechanism of action
                    whereas norepinephrine acts as a neurotransmitter.   of  cocaine and  tricyclic  antidepressants),  or  (3)  preventing the
                                                                         enzymatic metabolism of norepinephrine (monoamine oxidase
                    *                                                    and catechol-O-methyltransferase inhibitors). Some drugs have
                     The authors thank Drs. Vsevolod Gurevich and Aurelio Galli for helpful
                    comments.                                            both direct and indirect actions.

                                                                                                                       137
   146   147   148   149   150   151   152   153   154   155   156